Apheresis is an increasingly important procedure in the treatment of a variety of conditions, sometimes performed via peripheral access because of concern over major complications associated with central venous catheter (CVC) placement. This study sought to determine the safety and success for ultrasound and fluoroscopically guided, non-tunneled dual lumen CVCs placed for apheresis. Prospective data collection was made of 200 attempted CVC placements in the radiology department utilizing real time sonographic guidance. The complications relating to placement were noted in all and the number of passes required for venepuncture and whether a single wall puncture was achieved was recorded in 185 cases. Duration of catheterization and reason for line removal were recorded in all. Our study group included 71 donors providing peripheral blood stem cells for allogeneic transplant. CVCs were successfully placed in all patients, 191 lines in the internal jugular and seven in the femoral vein. 86.5% required only a single pass and 80.5% with only anterior wall puncture. Inadvertent but clinically insignificant arterial puncture occurred in six (3%) cases. In no case did this prevent line placement. There were no other procedure-related complications. 173 (87.4%) catheters were removed the same day. No catheters were removed prematurely. There was one case of prolonged venous bleeding. Our study demonstrates the safety of central venous catheters for apheresis provided that duration of catheterization is short and real-time sonographic guidance is used for the puncture, and guide wire and catheter placement are confirmed fluoroscopically.
Apheresis is an increasingly important technique for the treatment of a variety of conditions with peripheral blood stem cell transplants since both autografts and allografts are utilized in rapidly increasing numbers to treat a variety of malignancies. [1] [2] [3] While peripheral venous access can be used for these procedures, large bore CVCs consistently provide higher flow rates and therefore shorten apheresis time. 4 A further consideration, particularly relevant in patients for autologous PBSC transplantation, is the frequent lack of adequate peripheral venous access. More widespread use of CVCs for apheresis has been hampered by concerns about possible complications associated with the deployment and use of CVCs in patients requiring apheresis. 5 This is important to address as more healthy donors undergo apheresis to provide PBSC for allogeneic transplant and iatrogenic complications must be minimized. There are, however, few studies addressing these concerns and in particular no literature concerning the use of CVCs to harvest PBSC for allogeneic transplant. This is in contrast to the placement, use and complications of CVCs placed for other indications such as hemodialysis, parenteral nutrition, chemotherapy and antibiotic therapy, which are well reported. 6, 7 We report our experience of placement of large bore dual lumen CVCs for apheresis.
Materials and methods
Data were collected prospectively in a single center. There were 200 attempted CVC placements in 198 patients (85 men and 113 women) between April 1994 and November 1997. The mean age was 41.5 years (range 16-69 years). All of the CVCs placed were to harvest peripheral blood stem cells; for autologous transplant in 127 cases and allogeneic transplant in the remaining 71.
All CVCs were placed in the angiography suite in the radiology department. The procedures were performed by one of three staff interventional radiologists, interventional fellows or by supervised residents. Informed consent was obtained from all patients. If required, mild sedation was achieved with a small dose of intravenous midazolam hydrochloride (Versed; Roche, Mississauga, Ontario, Canada). No systemic antithrombotic prophylaxis or antibiotics were administered. Immediately prior to the procedure the internal jugular veins (IJV) were examined sonographically (Aloka SSD-2000, Tokyo, Japan 7.5 Hz probe) to confirm patency and size. The right IJV was preferred but if unsuitable or if the patient had an existing line for other reasons, then the left IJV was used. In patients in whom catheterization of either IJV was not possible a femoral puncture was performed. The operator and nurse wore masks, and performed a complete surgical scrub before donning surgical gowns and gloves. The patient, wearing a surgical hat, was placed in the supine position with the head turned away from the side of puncture. Following cleansing of the skin with a 10% w/v povidone-iodine solution (Triadene; H & P Industries, Franklin, WI, USA) the surgical site was iso-lated with sterile drapes. The site of puncture was determined by US; directly over the IJV 1-3 cm above the clavicle. Lidocaine 1% was instilled into the subcutaneous tissues at the intended puncture site. A 19-gauge needle (Brent Angio; Brent Surgical, Toronto, Ontario, Canada) was advanced into the vein just cranial to the probe using real time sonographic guidance. Whenever possible, puncture of the anterior IJV wall only was made. After successful venepuncture, a 0.035-inch diameter J tip guidewire (Cook, Bloomington, IN, USA) was advanced through the needle and the position of the tip in the right atrium or preferably inferior vena cava was confirmed with fluoroscopy. The track was then dilated and the catheter passed over the wire. All of the CVCs were temporary dual lumen catheters. The majority, 140 (70%), were dual lumen Flexxicon II 12F Vas-caths (Vas-cath, Mississauga, Ontario, Canada) of concentric design. The length of catheter chosen was determined by access site and patient habitus. The position of the catheter tip was confirmed fluoroscopically and recorded. Finally heparin, 10 000 units/ml, was instilled in each lumen and the exit site dressed with gauze and Hypafix. Use of all CVCs for apheresis was commenced shortly after placement on the day of insertion.
In 185/200 (92.5%) of cases the number of passes required for successful venepuncture and whether a single wall puncture was achieved, was recorded. Occurrence of complications related to venous puncture and placement of the line were recorded in all cases as: none, arterial puncture, pneumothorax, air embolism, bleeding or other. The number of days the CVC remained in situ and reason for removal (either completed use, thrombosed, suspected infection or other) was recorded in all cases. If catheterrelated infection was suspected then the tip of the CVC was sent for culture.
Results
Access to a central vein was successful in all cases with catheters placed in 198 of 200 attempts (99.5%). In two patients, there was successful cannulation of a patent compressible internal jugular vein but catheter placement was prevented by unsuspected inominate stenosis. These patients had a contralateral internal jugular in one case, and a transfemoral catheter in the other, successfully placed at the same sitting. All catheters were shown fluoroscopically to be appropriately placed. 191 of the lines were placed in an internal jugular vein (160 on the right and 31 on the left). Seven lines were placed in the femoral vein, all on the right. In 160/185 (86.5%) of punctures, a single needle pass only was required and in 149/185 (80.5%) this was achieved with a single wall puncture only.
Unintended arterial puncture occurred in six cases (3.0%), all in patients undergoing PBSC harvesting for autologous transplantation. In no case was there significant haematoma formation and after manual pressure had been applied to control bleeding a catheter was successfully placed at the same site in five and at another site in one. There were no other adverse events or clinical sequelae.
Of 198 catheters placed, 173 (87.4%) were removed the same day and a further 24 (12.1%) the following day. The remaining CVC was removed after 2 days. No CVCs were removed prematurely. There was one case of prolonged venous bleeding around the catheter puncture site in a stem cell donor. The clotting profile and platelet count were in the normal range. Despite this, apheresis was completed on the same day as the catheter insertion. Hemostasis was secured once the catheter was removed.
Discussion
Our study demonstrates a very low frequency of complications associated with the use of centrally placed venous catheters for apheresis if sonographic guidance is used for the puncture, guide wire and catheter placement are confirmed fluoroscopically, and the duration of catheterization is short. A number of factors are likely to contribute to our low complication rate.
Complications associated with the placement of a CVC for any purpose can be broadly divided into those associated with insertion and those that occur later. The main complications associated with insertion are misadventure related to venous puncture including inadvertent arterial puncture, arterial placement of the line, extravascular wire or catheter placement, venous laceration, cardiac perforation and tamponade, haemothorax and pneumothorax. The late complications are CVC related infection, thrombosis, mechanical failure and catheter dislocation. 7 We employ a number of measures to minimize the incidence of complications in our series. First, all punctures are performed using real time sonographic visualization of the vein which has been demonstrated to be superior to blind puncture. 8 This is reflected in the high percentage of first pass and single wall punctures. It has been shown that the most important predictor of CVC placement complications is the number of passes required to gain venous access. 9 A second measure is the selection of the internal jugular vein for CVC placement. Puncture of the subclavian vein, when compared to the internal jugular vein, is associated with a higher incidence of pneumothorax because of its proximity to the lung apex. It is also more difficult to accurately visualize the subclavian vein with ultrasound making guidance of the needle less reliable. The right internal jugular vein is used in preference to a left sided approach as it offers a more direct route, so reducing the incidence of mechanical difficulties associated with over the wire placement, and the possibility of trauma to the vein wall which may be a contributing factor to premature line failure. Finally, placement of CVCs for apheresis is performed by a restricted number of experienced radiologists, fellows and supervised residents.
Our acute complication rate compares favorably with that of other authors. Our data were collected prospectively with careful documentation of all procedure-related complications as well as the number of needle passes needed to gain venous access and whether this was achieved with a single anterior wall puncture. This is in contrast to the studies by Hahn et al, 4 Goldberg et al 5 2%) , three accidental carotid punctures resulting in hematomas exceeding 2 cm and one pneumothorax. They fail, however, to state the absolute number of arterial punctures. We note that their preferred access site was also the internal jugular vein and that they too used ultrasound to facilitate puncture. Interestingly, all but 28 CVCs placed were single lumen catheters requiring a second peripheral venous access site for reinfusion. They would only place a double lumen CVC if no peripheral site was available. In the study conducted by Goldberg et al 5 all CVCs were placed by a surgeon. In this series the complication rate is comparable (2.7%) although it is worth noting that in one case the complication was SVC perforation and cardiac tamponade requiring emergency thoracotomy, and in another, a pneumothorax. Inadvertent arterial puncture was not recorded. In a retrospective study by Alegre et al 10 110 CVCs were placed by anaesthetists with the subclavian route being preferred. They document one (1%) pneumothorax but do not record arterial puncture or related complications. Lines were placed without imaging, catheter position being confirmed by a post-procedure chest X-ray.
A possible factor explaining the low incidence of late complications (one case of prolonged venous bleeding) in our study is the short time that CVCs are in situ. In our center we perform large volume apheresis and monitor mobilization of PBSC to pick the optimal day for the procedure. We also monitor harvesting of stem cells during the apheresis, stopping the procedure when a predetermined number of cells has been obtained. Our average run is 6 h. 11 Consequently, 197 of 198 CVCs for PBSC harvesting were removed within 1 day of insertion. Short duration of catheretization is facilitated by catheters being placed in the early morning with patients being immediately transferred to the apheresis unit. This is of particular importance with respect to thrombotic and infection-related complications. Whilst CVC-related infection can be secondary to factors related to the insertion procedure these can be minimized by the use of strict aseptic technique. CVC-related infection is thought to be due to migration of skin organisms at the insertion site and CVC colonization or contamination of the catheter hub. There is conflicting evidence as to whether duration of catheterization is a risk factor for infection. 12, 13 However, even if the risk remains constant, the longer the CVC is in situ the more likely it is to become infected. In the small number of previous reports describing the use of CVCs for apheresis the catheters have been in place for longer than in our study. Goldberg et al 5 reported 75 patients who underwent 554 leukaphereses via CVCs. Twelve (16.0%) of the patients experienced infectious complications requiring removal of the line in three cases (4.0%). The CVCs were in place for a median of 5 days (range 3-141 days). Hahn et al 4 placed CVCs in 153 patients for apheresis. The median duration of CVC placement was 3 days (range 1-28 days) with five patients (3.3%) experiencing catheter site infection, and a further two patients (1.3%) a catheter-related septicemia. Alegre et al 10 reported a catheter site infection in four patients (3.6%) with no documented catheter-related septicemia. Their CVCs were in place for a median of 3 days (range 2-22 days). Our experience of no catheter-related infections in 198 line insertions compares very favorably and is likely due to the short duration of CVC placement and rapid large volume apheresis.
Thrombosis of the CVC is a further important cause of premature failure. Goldberg et al 5 found that 50% of their patients experienced at least one episode of CVC occlusion, requiring thrombolytic therapy with its inherent risks or premature catheter removal. Hahn et al 4 reported a thrombotic rate of 5% and Alegre et al 10 a thrombotic rate of 1.8%. Our absence of thrombotic complications is again likely to be due to the short duration of catheterization.
It is now well accepted that radiological placement of both tunneled and non-tunneled CVCs by interventional radiologists is both cheaper and associated with lower complication rates than traditional landmark placement by surgeons. 6, 7 The vast superiority of ultrasound guidance is similarly beyond dispute. 8 At our institution the total cost of a temporary CVC placement in radiology is C$250 with an average total procedure time of 15 min. The professional fee for a surgically placed catheter is comparable but in addition there is the added cost of operating room time, anesthetic fee and a longer total procedure time. A further factor favoring image-guided placement is the fact that radiologists have more control over their interventional suite than do surgeons with operating room time, allowing a more efficient line service. This is particularly important in our apheresis patients as line placement is coordinated with optimal stem cell mobilization. Using peripheral venous access for PBSC harvest is more common than utilizing CVCs, however, it requires considerably lengthened apheresis times (personal communication) with associated prolonged hospital stay. This outweighs the cost of a dual lumen central venous catheter and is less cost effective.
Our series compares very favorably with the albeit limited, published data on large bore central venous catheters for apheresis. We have shown that the internal jugular route is safe when the puncture is made using real time sonographic guidance, and by using fluoroscopy to facilitate guide wire and catheter placement we had no malplacements or complications of catheter placement. No catheter dislocations occurred and there was no case of a catheter being positionally dependent. All catheters allowed cytapheresis to be completed, most on the same day. Our late complications are the lowest published. In part this is felt to be due to the CVC being placed on the morning of the scheduled apheresis and most being removed the same day. In particular we feel we have addressed the previously neglected area of large bore dual lumen CVCs in healthy donors providing PBSC for allogeneic transplant. In our series, this group encountered only one minor complication of venous bleeding around the catheter site.
We believe radiologically placed double lumen CVCs via a jugular approach utilizing real time sonographic guidance and fluoroscopic screening are safe and can be advo-cated for all patients undergoing apheresis, including healthy PBSC donors.
